As of 2025-11-03, the EV/EBITDA ratio of bluebird bio Inc (BLUE) is -1.11. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLUE's latest enterprise value is 129.30 mil USD. BLUE's TTM EBITDA according to its financial statements is -116.20 mil USD. Dividing these 2 quantities gives us the above BLUE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.2x - 15.1x | 13.6x |
| Forward P/E multiples | 13.7x - 20.4x | 17.0x |
| Fair Price | (170.85) - (187.47) | (190.44) |
| Upside | -3537.7% - -3872.1% | -3931.8% |
| Date | EV/EBITDA |